Slides
Page 1
ab aldeyra April 27 , 2021 DATA RELEASE Top - Line Results from the Phase 3 INVIGORATE Trial in Allergic Conjunctivitis Nasdaq : ALDX © Aldeyra Therapeutics , Inc. 2021
Loading workspace
ab aldeyra April 27 , 2021 DATA RELEASE Top - Line Results from the Phase 3 INVIGORATE Trial in Allergic Conjunctivitis Nasdaq : ALDX © Aldeyra Therapeutics , Inc. 2021
Your watchlist and earnings event details are available after you sign in.